On the resistance to relapse to cocaine seeking following impairment of instrumental cocaine memory reconsolidation by Exton-McGuinness, Marc et al.
 
 
University of Birmingham
On the resistance to relapse to cocaine seeking
following impairment of instrumental cocaine
memory reconsolidation
Exton-McGuinness, Marc; Drame, Mohamed Lamine; Flavell, Charlotte; Lee, Jonathan
DOI:
10.3389/fnbeh.2019.00242
License:
Creative Commons: Attribution (CC BY)
Document Version
Publisher's PDF, also known as Version of record
Citation for published version (Harvard):
Exton-McGuinness, M, Drame, ML, Flavell, C & Lee, J 2019, 'On the resistance to relapse to cocaine seeking
following impairment of instrumental cocaine memory reconsolidation', Frontiers in Behavioral Neuroscience,
vol. 13, 242, pp. 1-11. https://doi.org/10.3389/fnbeh.2019.00242
Link to publication on Research at Birmingham portal
General rights
Unless a licence is specified above, all rights (including copyright and moral rights) in this document are retained by the authors and/or the
copyright holders. The express permission of the copyright holder must be obtained for any use of this material other than for purposes
permitted by law.
•	Users may freely distribute the URL that is used to identify this publication.
•	Users may download and/or print one copy of the publication from the University of Birmingham research portal for the purpose of private
study or non-commercial research.
•	User may use extracts from the document in line with the concept of ‘fair dealing’ under the Copyright, Designs and Patents Act 1988 (?)
•	Users may not further distribute the material nor use it for the purposes of commercial gain.
Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.
When citing, please reference the published version.
Take down policy
While the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been
uploaded in error or has been deemed to be commercially or otherwise sensitive.
If you believe that this is the case for this document, please contact UBIRA@lists.bham.ac.uk providing details and we will remove access to
the work immediately and investigate.
Download date: 01. Mar. 2020
ORIGINAL RESEARCH
published: 15 October 2019
doi: 10.3389/fnbeh.2019.00242
Edited by:
Devin Mueller,
Kent State University, United States
Reviewed by:
Marek Schwendt,
University of Florida, United States
Rafael Roesler,
Federal University of Rio Grande do
Sul, Brazil
*Correspondence:
Jonathan L. C. Lee
j.l.c.lee@bham.ac.uk
†Present address:
Charlotte R. Flavell,
Aston University, Birmingham,
United Kingdom
Specialty section:
This article was submitted to
Learning and Memory,
a section of the journal
Frontiers in Behavioral Neuroscience
Received: 27 June 2019
Accepted: 26 September 2019
Published: 15 October 2019
Citation:
Exton-McGuinness MTJ, Drame ML,
Flavell CR and Lee JLC (2019) On the
Resistance to Relapse to
Cocaine-Seeking Following
Impairment of Instrumental Cocaine
Memory Reconsolidation.
Front. Behav. Neurosci. 13:242.
doi: 10.3389/fnbeh.2019.00242
On the Resistance to Relapse to
Cocaine-Seeking Following
Impairment of Instrumental Cocaine
Memory Reconsolidation
Marc T. J. Exton-McGuinness , Mohamed L. Drame , Charlotte R. Flavell †
and Jonathan L. C. Lee*
School of Psychology, University of Birmingham, Birmingham, United Kingdom
Reconsolidation normally functions to update and maintain memories in the long-
term. However, this process can be disrupted pharmacologically to weaken memories.
Exploiting such experimental amnesia to disrupt the maladaptive reward memories
underpinning addiction may provide a novel therapeutic avenue to prevent relapse.
Here, we tested whether targeted disruption of the reconsolidation of instrumental
(operant) lever pressing for cocaine resulted in protection against different forms of
relapse in a rat self-administration model. We first confirmed that systemic injection of
the non-competitive N-methyl–D-aspartate receptor (NMDAR) antagonist MK-801 did
impair reconsolidation to reduce spontaneous instrumental drug-seeking memory at test.
This deficit was not rescued by pharmacological induction of stress with the anxiogenic
α2-noradrenergic receptor antagonist yohimbine. In contrast, cocaine-seeking was
restored to control levels following priming with cocaine itself, or presentation of a
cocaine-associated cue. These results suggest that while stress-induced relapse can
be reduced by disruption of instrumental memory reconsolidation, the apparent sparing
of the pavlovian cue-drug memory permitted other routes to relapse. Therefore, future
reconsolidation-based therapeutic strategies for addictive drug-seeking may need to
target both instrumental and pavlovian memories.
Keywords: cocaine, addiction, instrumental, memory, reconsolidation, relapse
INTRODUCTION
Memories are constantly evolving through a constructive process that serves to update their
content. One core mechanism of memory updating is believed to be memory reconsolidation
(Nader, 2003; Lee, 2009). Following appropriate retrieval, believed to involve some form of
prediction error (Exton-McGuinness et al., 2015), a memory can be destabilized, requiring that
it is subsequently restabilized in a reconsolidation process that necessitates activity at N-methyl–D-
aspartate receptors (NMDARs), gene expression, and protein synthesis (Tronson and Taylor, 2007).
Abbreviations: CS, conditioned stimulus; NMDAR, N-methyl–D-aspartate receptor; VR5, variable ratio 5.
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Pharmacologically impairing the restabilization of a memory
during the reconsolidation phase can induce amnesia. This
finding has generated much interest in treating disorders
underpinned bymaladaptivememories (Kindt et al., 2009; Taylor
et al., 2009; Milton, 2013).
It has been suggested that addictions are driven by the
formation of a maladaptive ‘‘habit’’ memory (Milton and Everitt,
2012), which supports the underlying behavioral compulsion to
seek drugs, regardless of consequences, that characterizes the
state of addiction (Koob and Volkow, 2010). Importantly, both
instrumental (operant) associations and pavlovian conditioned
stimuli (CSs) contribute to the performance and maintenance of
drug-seeking behaviors (Belin et al., 2013; Hogarth et al., 2013).
This is critical in understanding relapse, as each bout of relapse
is often precipitated by exposure to stress, the drug itself or a
drug-associated CS (Bossert et al., 2005).
Addictive drug memory reconsolidation studies have
predominantly focussed on pavlovian cue-drug memories,
showing that these memories can be disrupted to reduce
cue-induced drug-seeking and relapse in both animal models
(Milton et al., 2008a) and human populations (Xue et al., 2012).
However, given that relapse can also occur following induction
of stress (Shaham et al., 2000) or re-exposure to the drug itself
(Jaffe et al., 1989), and that impairment of pavlovian cocaine
memory reconsolidation does not appear to protect against
cocaine-induced relapse (Sanchez et al., 2010), the potential for
long-lasting therapeutic benefit may be limited.
As addictive drug-seeking requires intact instrumental
memory and expression, it is possible that targeting the
instrumental memory for reconsolidation disruption might
provide more robust protection against stress- and drug-induced
relapse. We have previously demonstrated that instrumental
memories can be impaired by the NMDAR antagonist MK-
801, under conditions of brief training with both sucrose
and intravenous cocaine reinforcement (Exton-McGuinness
and Lee, 2015), and more extensive sucrose reinforcement
(Exton-McGuinness et al., 2014), findings that are consistent
with the effects of NMDAR antagonists to impair memory
reconsolidation in other settings (Sadler et al., 2007; Winters
et al., 2009; Reichelt and Lee, 2012, 2013). In the present
study, we used an intravenous (i.v.) self-administration
paradigm to investigate: (1) whether reconsolidation-disruption
of instrumental cocaine memory can reduce spontaneous
drug-seeking after an established period of self-administration;
and (2) whether reconsolidation-disruption of instrumental
memory could also provide resistance to relapse triggered
via pharmacological stress [mimicking physiological and
psychological stress with the anxiogenic α2-noradrenergic
receptor antagonist yohimbine (Stine et al., 2002; Feltenstein
and See, 2006)], re-exposure to cocaine, or presentation of a
drug-associated cue.
MATERIALS AND METHODS
Subjects were 124 experimentally naïve male Hooded-Lister rats
(Charles River, UK) weighing 250–350 g (median 275 g) at the
beginning of the experiment. Rats were kept in a conventional
animal facility on a 12 h light/dark cycle (lights on 0700), housed
in quads in individually ventilated cages with two levels; the lower
contained aspen chip bedding. Environmental enrichment was
available in the form of wood chew blocks and paper house.
Food and water were provided ad libitum. Experimental sessions
took place 0800–1600 each day. At the end of the experiment,
all animals were humanely killed via a rising concentration of
CO2. All procedures were approved by a local ethical review
board and carried out in accordance with the UK Animals
(Scientific Procedures) Act 1986, Amendment Regulations 2012
(PPL P8B15DC34 and PPL P3B19B9D2).
Surgical Procedures
Drinking water was supplemented with the broad-spectrum
antibiotic Baytril for 7 days, beginning 3 days pre-operatively.
Rats were anesthetized using isoflurane (5% induction, 2%–3%
maintenance), and administered peri- and post-operative
buprenorphine; their diet was also supplemented with the
non-steroidal anti-inflammatory Carprofen for 1 days pre-
operatively, and 3 days post. Rats were allowed a minimum
of 7 days recovery, during which they were singly housed on
Puracel bedding; rats were rehoused in quads at the start of
experimental procedures.
Surgeries were carried out aseptically during which rats
were implanted with chronic indwelling jugular vein catheters
(Polyurethane Intravascular Tubing; Instech, PA, USA) aimed at
the left vena cava, secured with silk suture, and exteriorized on
the dorsum with a small plastic implant (PlasticsOne, Roanoke,
VA, USA; 313-000BM-15-5UP/1/SPC) secured to the skin with a
1 inch mesh.
Drugs
Cocaine HCl (Macfarlane Smith Ltd, UK) was dissolved in sterile
saline to a concentration of 2.5 mg/ml; i.v. infusions of 0.1 ml
over 5.6 s could be obtained during training and reactivation.
Infusion dosage was based upon established literature (Di
Ciano and Everitt, 2001). For cocaine-primed reinstatement,
10 mg/kg of cocaine solution was injected intraperitoneally (i.p.)
immediately before the behavioral session; this dose is known to
reinstate lever pressing for cocaine (Brimijoin et al., 2008).
MK-801 (AbCam, UK) was dissolved in sterile saline
to a concentration of 0.1 mg/ml. Thirty minutes prior to
memory reactivation rats were injected i.p. with 0.1 mg/kg of
MK-801 or saline vehicle. This dose is established to disrupt
instrumental memory reconsolidation (Exton-McGuinness et al.,
2014; Exton-McGuinness and Lee, 2015). Injections were
assigned systematically by cage, randomly within each cage.
Yohimbine (Sigma-Aldrich, UK) was dissolved in sterile
saline to a concentration of 1.25 mg/ml. For stress-induced
reinstatement, yohimbine was administered 30 min prior to
testing (1.25 mg/kg). This dose is established to reinstate
drug-seeking in cocaine settings (Feltenstein and See, 2006).
Behavioral Procedures
Behavioral sessions took place in eight operant boxes
(MedAssociates, VT), as described previously (Exton-
McGuinness and Lee, 2015). Prior to each session catheters were
flushed with heparinized saline (0.1 ml, 30 IU/ml). Catheters
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were then connected to an infusion pump (MedAssociates,
VT, USA) and secured with a spring tether. The study
consisted of five experiments each with the same training
and reactivation protocols, however, testing was conducted in
one of five conditions: (1) spontaneous seeking; (2) CS-induced
relapse; (3) yohimbine-induced stress; (4) cocaine priming; and
(5) yohimbine + CS relapse.
Training
Rats were trained to self-administer cocaine for 10 days, on
a fixed-ratio-1 schedule. Two levers were extended into the
chamber; one assigned the ‘‘active’’ cocaine-reinforced lever.
Lever assignments were made systematically prior to the start
of training. Active responses triggered delivery of a single
cocaine infusion and a 20-s illumination of a light CS above
the active lever, during which the houselight went out. Both
levers remained extended throughout the session, and inactive
responses had no consequence. A 20-s timeout was enforced
between infusions. Training sessions lasted 90 min, or were
terminated when a maximum of 30 infusions were received.
Reactivation
Forty-eight hours after the final training day, rats were injected
i.p. with MK-801, or saline, 30 min prior to a variable-ratio
(VR5) reactivation session (Exton-McGuinness and Lee, 2015).
VR5 required a random number of active lever presses to gain
an infusion (mean: 5, range: 1–9). Reactivation lasted 20 min,
or until the maximum of 20 infusions was obtained. Cocaine
infusions were as in training: accompanied by a CS (20 s) with
a 20-s time-out between infusions.
Testing
The following day, responding was tested in a 90-min extinction
session. Levers were extended throughout, and no cocaine
was delivered. The drug-paired CS was only presented in
the CS-relapse and Yohimbine+CS-relapse conditions and was
absent in all other tests. For yohimbine-, yohimbine+CS and
cocaine-induced relapse, rats were pre-treated with yohimbine or
cocaine, respectively.
Statistical Analyses
Data are represented as mean ± SEM, and were analyzed using
JASP 0.9.1 (JASP Team, 2016). The primary analyses were
frequentist, with alpha = 0.05 and η2p reported as an index of
effect size. Parametric assumptions were tested using Levene’s
test for equality of variances. For acquisition data, Session was
included as a factor; where appropriate a Greenhouse-Geisser
correction was applied to correct for sphericity violations. The
primary outcome of interest was the discriminated responding
between the active and inactive levers. Drug treatment was
assigned pseudo-randomly to produce two groups similarly
performing during training. Test sessions were analyzed divided
into two equal time bins (1 vs. 2) as per previous analytical
approaches (Lee et al., 2006). For the Yohimbine+CS relapse
experiment, the data were analyzed withMK-801 and Yohimbine
drug factors in independent analyses, with planned follow-up
comparisons (e.g., effect of MK-801 in Yohimbine groups). We
also report BFInclusion from parallel Bayesian analyses (Cauchy
prior r = 0.707) as an estimate of posterior probability.
Four rats were culled prior to the start of the experiment
owing to problems during surgical recovery, and seven during
training due to biological rejection of catheters. Eight rats
were excluded due to catheter blockages, four rats were
excluded due to equipment failures, and two rats were excluded
owing to a failure to learn the task (<25 infusions during
training). Four rats were excluded from the Yohimbine+CS
relapse experiment as their test data were >2 SD from the
group mean.
RESULTS
Experiment 1: Disruption of Spontaneous
Drug-Seeking
Differences at test could not be attributed to prior differences
during training (Figure 1) as both groups learned to respond
predominantly on the active lever and performed similarly prior
to reactivation (MK-801 × Lever × Session: F(5.2,97.9) = 0.20,
p = 0.97, η2p = 0.010, BFinc < 0.001; MK-801 × Lever:
F(1,19) = 0.27, p = 0.61, η2p = 0.014, BFinc = 0.13; MK-801:
F(1,19) = 0.33, p = 0.57, η2p = 0.017, BFinc = 0.12).
Forty-eight hours after training, rats were injected i.p.
with MK-801 (or saline vehicle) 30 min prior to a short
VR5 reactivation session in which the reward contingency
was altered. Responding of MK-801 treated individuals was
generally reduced (MK-801: F(1,19) = 6.97, p = 0.016, η2p = 0.27,
BFinc = 3.17); however, rats still showed some evidence
of discrimination between the levers (MK-801 × Lever:
F(1,19) = 3.19, p = 0.090, η2p = 0.14, BFinc = 3.87).
On the following day, spontaneous cocaine-seeking
performance was tested in extinction, in the absence of cocaine
or the CS. MK-801-treated rats showed poorer discriminated
responding on the active vs. inactive lever across the test
session (MK-801 × Lever: F(1,19) = 12.7, p = 0.002, η2p = 0.40,
BFinc = 67.9; MK-801 × Lever × Bin: F(1,19) = 0.48, p = 0.50,
η2p = 0.025, BFinc = 1.87). This suggests MK-801 successfully
disrupted instrumental cocaine memory reconsolidation.
Experiment 2: CS-Induced Relapse
A second cohort of rats was trained as before with no
group differences prior to reactivation and drug administration
(Figure 2; MK-801 × Lever × Session: F(3.3,36.8) = 0.44, p = 0.75,
η2p = 0.038, BFinc = 0.001;MK-801× Lever: F(1,11) = 0.12, p = 0.74,
η2p = 0.011, BFinc = 0.099; MK-801: F(1,11) = 0.36, p = 0.56,
η2p = 0.031, BFinc = 0.12).
After a 48-h rest period, rats were administered MK-801
or saline as previously prior to a VR5 reactivation. There
were no significant group differences in lever responding (MK-
801 × Lever: F(1,11) = 1.46, p = 0.25, η2p = 0.12, BFinc = 1.44);
however as previously observed, response rates were generally,
although not significantly, lower in the MK-801 group (MK-801:
F(1,11) = 3.08, p = 0.11, η2p = 0.22, BFinc = 0.95).
At test, active responses triggered a 1-s presentation of the
CS light above the lever. Under these test conditions, there was
no evidence for an impairment in discriminated responding in
previouslyMK-801-treated rats (MK-801× Lever: F(1,11) = 0.015,
p = 0.90, η2p = 0.001, BFinc = 0.35; MK-801 × Lever × Bin:
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FIGURE 1 | Long-term lever pressing was significantly impaired at test following administration MK-801 in conjunction with a reactivation session. (A) Schematic of
the experiment. (B) Rats learned to self-administer cocaine over training days 1–10 (T1–T10). At reactivation (R), overall responding was acutely reduced by MK-801
(n = 12) administration compared to saline-injected controls (n = 9), however, this was not specific to either lever. In a 90-min extinction test, previously MK-801
treated rats made significantly fewer responses on the active (previously cocaine paired) lever. Data are presented as summary mean ± SEM.
FIGURE 2 | Presentation of a cocaine-paired conditioned stimulus (CS) maintained lever pressing at test, regardless of prior disruption of reconsolidation with
MK-801. (A) Schematic of the experiment. (B) Rats acquired cocaine-seeking successfully over training days 1–10 (T1–T10). At reactivation (R), lever pressing was
slightly reduced by MK-801 (n = 7) compared to saline controls (n = 6), although this was not statistically significant. During testing, active lever responses triggered a
1 s presentation of the cue light. This was sufficient to recover responding of MK-801 treated rats to control levels. Data are presented as summary mean ± SEM.
F(1,11) = 0.71, p = 0.42, η2p = 0.061, BFinc = 0.061; MK-
801: F(1,11) = 0.65, p = 0.44, η2p = 0.056, BFinc = 0.33).
Therefore, the cocaine-associated light cue was able to recover
cocaine-seeking.
Experiment 3: Yohimbine-Induced Relapse
A third cohort learned to self-administer cocaine, with treatment
groups performing similarly prior to reactivation (Figure 3;
MK-801 × Lever × Session: F(9,117) = 1.01, p = 0.44, η2p = 0.072,
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FIGURE 3 | Induction of stress using the α2 antagonist yohimbine failed to reinstate lever pressing following reconsolidation-disruption with MK-801. (A) Schematic
of the experiment. (B) Rats learned to lever press for cocaine over training days 1–10 (T1–T10). At reactivation (R), overall lever pressing was acutely reduced by
MK-801 (n = 7) compared to saline controls (n = 8), however, this was not specific to either lever. Thirty minutes prior to testing all rats were injected with yohimbine
and tested in extinction (with no discrete stimuli present). Rats previously treated with MK-801 remained significantly impaired, suggesting stress is not sufficient to
rescue performance following disruption of instrumental memory. Data is presented as summary mean ± SEM.
BFinc = 0.009;MK-801× Lever: F(1,13) = 0.53, p = 0.48, η2p = 0.039,
BFinc = 0.35; MK-801: F(1,13) = 0.19, p = 0.67, η2p = 0.014,
BFinc = 0.20).
At reactivation there was again evidence for an acute overall
reduction in responding followingMK-801 administration (MK-
801: F(1,13) = 5.91, p = 0.030, η2p = 0.31, BFinc = 1.99), and
although it is somewhat unclear statistically whether this was
specific to either lever (MK-801× Lever: F(1,13) = 2.73, p = 0.122,
η2p = 0.17, BFinc = 3.1), numerically the reduction was apparent
across both levers.
Thirty minutes prior to testing all rats were injected with
yohimbine. Under these test conditions MK-801-treated rats
had impaired discrimination (MK-801 × Lever: F(1,13) = 7.51,
p = 0.017, η2p = 0.37, BFinc = 48.2) that was time-dependent
within the session (MK-801 × Lever × Bin: F(1,13) = 4.62,
p = 0.051, η2p = 0.26, BFinc = 26.7). Analysis of simple effects
revealed amore obvious effect in the first half of the session (MK-
801 × Lever: F(1,13) = 6.52, p = 0.024, η2p = 0.33, BFinc = 16.7)
than in the second half (MK-801× Lever: F(1,13) = 3.03, p = 0.11,
η2p = 0.19, BFinc = 2.1; MK-801: F(1,13) = 2.47, p = 0.14, η2p = 0.16,
BFinc = 1.5). Therefore, yohimbine failed to recover the MK-801-
induced deficit in instrumental cocaine-seeking.
Experiment 4: Yohimbine+CS-Induced
Relapse
Another cohort learned to self-administer cocaine as
before with no significant group differences (Figure 4;
MK-801× Lever× Session: F(4.4,122.7) = 0.66, p = 0.64, η2p = 0.023,
BFinc = 0.086;MK-801× Lever: F(1,28) = 1.40, p = 0.25, η2p = 0.048,
BFinc = 2.06; MK-801: F(1,28) = 1.32, p = 0.26, η2p = 0.045,
BFinc = 0.84; YOH× Lever× Session: F(4.3,119.6) = 0.30, p = 0.89,
η2p = 0.011, BFinc < 0.001; YOH × Lever: F(1,28) = 0.31, p = 0.58,
η2p = 0.011, BFinc = 0.096; YOH: F(1,28) < 0.001, p = 0.97,
η2p = 0.000, BFinc = 0.10).
Forty-eight hours after training rats were, as previously,
injected with MK-801 or vehicle prior to reactivation. There
was no significant acute effect of MK-801 treatment during this
session (MK-801 × Lever: F(1,28) = 0.076, p = 0.79, η2p = 0.003,
BFinc = 0.57; MK-801: F(1,28) = 1.76, p = 0.20, η2p = 0.059,
BFinc = 0.57). In contrast, the groups that would subsequently
be treated with yohimbine responded more than those to be
administered saline (YOH × Lever: F(1,28) = 10.9, p = 0.003,
η2p = 0.28, BFinc = 47.9), which was surprising given the lack
of any difference during training. However, this effect was only
observed in MK-801-injected rats (YOH × Lever: F(1,13) = 9.30,
p = 0.009, η2p = 0.42, BFinc = 20.1), and not in the saline control
condition (YOH × Lever: F(1,13) = 2.24, p = 0.16, η2p = 0.15,
BFinc = 1.30).
Rats were injected with yohimbine or vehicle 30 min
prior to a test, in which active lever presses were reinforced
by the light CS. In order to evaluate the capacity of
yohimbine to elevate responding at test, we analyzed first
the overall effect of yohimbine (Figures 4B,C). There was
evidence that yohimbine did increase performance across the
test (YOH × Lever: F(1,28) = 4.46, p = 0.044, η2p = 0.14,
BFinc = 3.84; YOH × Lever × Bin: F(1,28) = 0.005, p = 0.95,
η2p = 0.000, BFinc = 0.22). Planned comparisons revealed
evidence for the yohimbine-induced enhancement in the non-
MK-801-treated rats (YOH × Lever: F(1,13) = 4.98, p = 0.044,
η2p = 0.28, BFinc = 11.9; YOH × Lever × Bin: F(1,13) = 0.34,
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FIGURE 4 | Administration of yohimbine did elevate instrumental responding in the presence of the CS, but not obviously in MK-801-treated rats. (A) Schematic of
the experiment. (B) Rats receiving vehicle prior to test. (C) Rats receiving yohimbine prior to test. Rats learned to lever press for cocaine over training days 1–10
(T1–T10). At reactivation (R), there was no acute effect of MK-801 on performance, but the groups did differ depending on whether they subsequently received
yohimbine. Thirty minutes prior to testing rats were injected with yohimbine or vehicle and were tested with active lever presses reinforced by the CS. Yohimbine
elevated test responding, more obviously in saline-treated rats. CS presentation recovered responding in the absence of yohimbine, but less obviously so with
pre-test yohimbine. Data are presented as summary mean ± SEM (yohimbine groups: n = 7; vehicle groups: n = 8).
p = 0.57, η2p = 0.025, BFinc = 0.53), but not in the MK-
801-treated group (YOH × Lever: F(1,13) = 0.37, p = 0.55,
η2p = 0.028, BFinc = 0.33; YOH × Lever × Bin: F(1,13) = 0.10,
p = 0.75, η2p = 0.008, BFinc = 0.08; YOH: F(1,13) = 0.38,
p = 0.55, η2p = 0.029, BFinc = 0.33). Therefore, there
was evidence that pre-test yohimbine was able to elevate
cocaine-seeking.
There was no overall effect of MK-801 (MK-801 × Lever:
F(1,28) = 2.01, p = 0.17, η2p = 0.067, BFinc = 0.74;
MK-801 × Lever × Bin: F(1,28) = 0.082, p = 0.78,
η2p = 0.003, BFinc = 0.11; MK-801: F(1,28) = 1.01, p = 0.33,
η2p = 0.035, BFinc = 0.48). Planned comparisons revealed
no effect of MK-801 in the non-yohimbine groups
(Figure 4B; MK-801 × Lever: F(1,14) = 0.004, p = 0.95,
η2p = 0.000, BFinc = 0.30; MK-801 × Lever × Bin: F(1,14) = 0.24,
p = 0.63, η2p = 0.017, BFinc = 0.072; MK-801: F(1,14) = 0.009,
p = 0.93, η2p = 0.001, BFinc = 0.28), with somewhat less
clear evidence in the yohimbine-treated groups (Figure 4C;
MK-801 × Lever: F(1,12) = 3.26, p = 0.096, η2p = 0.21,
BFinc = 0.74; MK-801 × Lever × Bin: F(1,12) = 0.058, p = 0.81,
η2p = 0.005, BFinc = 0.099; MK-801: F(1,12) = 1.67, p = 0.22,
η2p = 0.12, BFinc = 0.48). Therefore, it remains unclear whether
combination of yohimbine and the CS was able to recover the
lever responding fully.
Experiment 5: Cocaine-Induced Relapse
The final cohort learned to self-administer cocaine.
There was evidence for an overall difference between
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FIGURE 5 | Administration of a cocaine-priming injection successfully rescued lever pressing on the active drug-lever, following MK-801 induced disruption of
reconsolidation. (A) Schematic of the experiment. (B) Rats acquired cocaine-seeking successfully over the training period (T1–T10), although there were differences
between the groups. At reactivation (R), overall lever pressing was slightly reduced by MK-801 administration (n = 7), although this was not significantly different to
saline controls (n = 9). Immediately prior to testing rats were injected with 10 mg/kg cocaine, which subsequently rescued responding on the active lever in the
MK-801 group. There was no difference at test between the groups, even when corrected for training history. Data are presented as summary mean ± SEM.
the groups in their discriminated responding (Figure 5;
MK-801 × Lever: F(1,14) = 4.87, p = 0.044, η2p = 0.26,
BFinc = 792.0; MK-801 × Lever × Session: F(2.3,32.5) = 1.08,
p = 0.36, η2p = 0.071, BFinc = 0.009), with the rats to be
injected with MK-801 performing to a higher level. This is
somewhat problematic for evaluating post-learning differences
in behavior, and may explain the lack of acute effect of
MK-801 on the VR5 reactivation session (MK-801 × Lever:
F(1,14) = 0.60, p = 0.45, η2p = 0.041, BFinc = 0.70; MK-
801: F(1,14) = 0.33, p = 0.57, η2p = 0.023, BFinc = 0.46), in
that the MK-801-injected rats might have been expected
to perform better than saline controls on the basis of
training history.
Twenty-four hours after reactivation, rats were injected
i.p. with cocaine immediately before testing commenced.
Under these test conditions, there was no evidence for an
impairment in discriminated responding in previously MK-
801-treated rats (MK-801 × Lever: F(1,14) = 0.022, p = 0.65,
η2p = 0.016, BFinc = 0.36; MK-801 × Lever × Bin: F(1,14) = 1.12,
p = 0.31, η2p = 0.074, BFinc = 0.064; MK-801: F(1,14) = 0.004,
p = 0.95, η2p = 0.000, BFinc = 0.30). In an exploratory
analysis to control partially for the different training history
between the two groups, we reanalyzed the total active lever
responses across the test session using an ANCOVA, with total
rewards earned during training as the covariate. This analysis
provided further support for there being no difference between
the groups at test (F(1,13) = 0.035, p = 0.85, η2p = 0.003,
BFinc = 0.45). Therefore, cocaine priming was able to recover
cocaine-seeking.
DISCUSSION
In the present studies, the combination of instrumental
cocaine memory reactivation in a brief VR5 session and
pre-reactivation systemic treatment with MK-801 reduced
subsequent cocaine-seeking under certain test conditions.
Reduced cocaine-seeking was observed in a test of spontaneous
drug-seeking, as well as following pharmacological challenge
with yohimbine. However, apparently normal seeking behavior
was observed in tests of cue-induced and cocaine-induced
cocaine-seeking. Therefore, while the targeting of instrumental
cocaine memory reconsolidation has complementary
beneficial effects to disruption of pavlovian cocaine memory
reconsolidation, both appear not to confer resistance to
cocaine-induced relapse.
Administration of the NMDAR antagonist MK-801 prior to
VR5 reactivation reduced long-term responding for cocaine on
the next day when tested in the absence of explicit precipitants
of relapse. This is consistent with our previous observations
that memory reactivation involving a shift to a variable reward
contingency successfully destabilizes instrumental sucrose
memory, allowing reconsolidation to be disrupted with MK-801
(Exton-McGuinness et al., 2014). A similar finding was also
observed for weakly-trained instrumental memories for both
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sucrose and cocaine reward (Exton-McGuinness and Lee,
2015). Here, we implemented an adapted protocol in which our
VR5 reactivation was given 48 h after training, as delaying the
reactivation session appears to facilitate destabilization in sucrose
settings (Cheng C., Lee J.L.C. and Exton-McGuinness M.T.J.,
unpublished observations). Given our previous demonstration
that the decrease in lever pressing is due to disruption of
instrumental memory (Exton-McGuinness and Lee, 2015),
it is highly likely that the present reduction in cocaine-
seeking is similarly caused by destabilization and disruption
of instrumental cocaine memory. That said, the seemingly
consistent effect of pre-reactivationMK-801 to lower responding
during the reactivation session is in marked contrast to the
elevation of responding observed in our previous instrumental
sucrose memory reconsolidation study (Exton-McGuinness
et al., 2014) and might point to alternative interpretations.
If MK-801 were acutely affecting memory retrieval, there
remains the possibility that such an impairment may be
long-lasting. Alternatively, the effect of MK-801 to increase
locomotor activity (Hargreaves and Cain, 1995) could become
linked to memory retrieval, thereby impacting upon later test
performance. This latter suggestion bears some similarity to
the recent hypothesis that reconsolidation impairments can be
interpreted not as mnemonic disruptions, but as the integration
of new information that influences subsequent memory retrieval
(Gisquet-Verrier and Riccio, 2018).
Importantly for future clinical application, reconsolidation-
disruption of lever pressing was not recovered by the anxiogenic
α2 antagonist yohimbine. Yohimbine has been observed to
reinstate extinguished lever pressing, for cocaine (Feltenstein and
See, 2006), nicotine (Feltenstein et al., 2012) and heroin (Banna
et al., 2010) at the doses used here. However, in the present
study, no recovery of responding was observed in previously
MK-801-treated animals. This result indicates an inability of (at
least pharmacological) stress to rescue the reconsolidation deficit,
even though the same stress induction manipulation was able
to elevate test responding in a control condition, compared to
vehicle pre-treatment (Yohimbine+CS experiment).
In contrast to the effects of yohimbine, response-contingent
CS presentation rescued performance to control levels. This
demonstrates firstly that any deficits in lever pressing caused by
MK-801 administration were not due to any motor incapacity
to respond, as cocaine-seeking was recovered to apparently
normal levels under certain test conditions. Secondly, pavlovian
cue-cocaine memory was evidently spared by the MK-801 +
VR5 reactivation reconsolidation manipulation, as the cocaine
cue retained its ability to modulate cocaine-seeking. This implies
that pavlovian CS associations were not destabilized by the
VR5 reactivation session and demonstrates that instrumental
and pavlovian memories that share the same rewarding
outcome can be selectively destabilized. This complements
previous demonstrations that reactivation sessions promoting
the destabilization of pavlovian CS-cocaine associations do
not affect the underlying lever pressing, suggesting intact
instrumental memory and hence selectivity to pavlovian
memory destabilization (Lee et al., 2006; Milton et al.,
2008a). While these observations reinforce our conclusion
that instrumental memory was disrupted in the present study,
they also raise an important issue for clinical translation
in that the destabilization and/or reconsolidation of both
pavlovian and instrumental memories have not yet been
shown to be possible within a single reactivation session. An
important caveat, however, to these conclusions is the apparent
discrepancy in the training history of the CS relapse rats in
our Experiment 2 (µ = 216 total cocaine infusions), compared
to the rats in the other experiments (µ = 148–164 across
experiments). It is possible that the greater strength of the
conditioned instrumental cocaine memory resulting from the
increased number of cocaine infusions may have provided a
boundary condition on instrumental memory destabilization
under the present reactivation parameters. If this were the
case, the apparent recovery with CS presentation would in
fact, reflect a lack of underlying instrumental impairment,
leaving open the possibility that disrupted instrumental
cocaine memory reconsolidation is not recovered by response-
contingent CS presentation. Such a conclusion is, however,
weakened by our observations in experiment 4, in which
the groups treated with vehicle, rather than yohimbine,
also show no evidence for an effect of MK-801 in a test of
cue-induced relapse despite the markedly reduced cocaine
intake history.
It is particularly notable that our reactivation protocol did
not destabilize pavlovian memory, as previous studies have
successfully destabilized cocaine memory with simple brief CS
exposure (Lee et al., 2006) and our VR5 reactivation also
included CS presentation. Operationally it appears that which
memory trace is destabilized depends upon the functional
features of the reactivation (i.e., what new information
is presented). Changing the response-reward contingency
destabilizes instrumental memory (Exton-McGuinness et al.,
2014) while altering cue-reward contingency causes pavlovian
memories to undergo reconsolidation (Lee et al., 2006;
Milton et al., 2008b). However, it remains unclear how
destabilization of pavlovian and instrumental memories interact
with each other.
Returning to the lack of stress-induced relapse, it is
worth noting that yohimbine, and stress more generally,
appear to have strong effects upon CS-mediated forms
of reinstatement (Feltenstein and See, 2006; Banna et al.,
2010). Our results do not show clearly whether or not
yohimbine, while ineffective in recovering spontaneous cocaine-
seeking, is able to act synergistically to enhance cue-induced
relapse. In our Yohimbine+CS experiment, yohimbine did
not elevate cue-induced cocaine-seeking in MK-801-treated
rats, even though it did increase responding in saline-treated
controls. This suggests an inability of stress to potentiate
cue-induced cocaine-seeking following instrumental memory
reconsolidation impairment. In contrast, there was little
statistical evidence for an effect of MK-801, compared to
saline, on yohimbine-stimulated cue-induced cocaine-seeking
at test, indicating that yohimbine might be able to recover
behavior to near-normal levels. Inspection of the numerical
results, however, suggests that the MK-801-treated rats did
respond at lower levels than saline controls. Moreover,
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the failure of yohimbine to elevate seeking in MK-801-
treated rats was certainly not due to any ceiling effect.
Therefore, our results are most consistent with the conclusion
that the previous failure of yohimbine to recover impaired
cocaine-seeking is not simply due to the absence of the CS
at test.
In contrast to yohimbine, and similarly to cue-induced
relapse, cocaine priming was effective in recovering cocaine-
seeking at test. It should be noted that the cocaine-induced
relapse test was conducted in the absence of explicit cues,
a setting previously demonstrated to attenuate amphetamine-
primed reinstatement of amphetamine seeking (Stretch et al.,
1971); nevertheless, there was evidence that cocaine priming did
quantitatively elevate responding, at least with visual inspection
of the MK-801 groups.
The present pattern of results, with protection afforded
only to stress-induced relapse, informs the important
question of how cocaine priming and response-contingent
CS presentation restored cocaine-seeking, given the background
of an instrumental memory impairment. There are several
potential accounts for such recovery. A first explanation focusses
on the capacity of cues and cocaine to induce craving for the
cocaine outcome, which can drive instrumental responding
(Schmidt et al., 2005; Shaham and Hope, 2005). However,
such an account relies upon responding being only partially
disrupted, as was seemingly the case in our results. Why
recovery is statistically complete, rather than demonstrating
enhancement of impaired responding but to lower levels
than control, is unclear but may simply reflect ceiling
effects, rather than a true complete recovery. Nevertheless,
the lack of recovery following yohimbine treatment is not
easily explained within a craving framework, as stress has
similarly been argued to precipitate relapse via induction
of craving (Sinha et al., 1999) and yohimbine can similarly
induce objective and subjective stress, and accompanying
drug-craving (Stine et al., 2002). Perhaps then, a focus on drug
sensitization may be more relevant, given first the difficulty in
applying the concept of craving to rodent behavior, and more
importantly the dissociation between CS and cocaine effects
on mesocorticolimbic dopamine, as opposed to yohimbine
effects on CRF release (Stewart, 2000; Shalev et al., 2002, 2010).
Moreover, while drug self-administration can sensitize stress
response systems (Sarnyai et al., 2001), resulting in enhanced
stress-induced responding (Ahmed et al., 2000; Shalev et al.,
2001), the latter are typically observed with longer access to
cocaine or longer training histories than those used in the
present study.
A second explanation for the recovery in cue- and cocaine-
induced relapse tests appeals to the debate surrounding the
nature of reconsolidation impairments. While traditionally
considered to reflect storage impairments (Lee, 2009), it has
also been argued that performance deficits result from state-
dependent learning effects (Millin et al., 2001) or, more
recently, integration of new information (Gisquet-Verrier
et al., 2015). The latter hypotheses emphasize observations
of recovery from amnesia. Cocaine-primed and cue-induced
reinstatement are predicated, at least in part, on the capacity
of cocaine and cues to remind and reinstate the extinguished
and inhibited instrumental memories (Shalev et al., 2002).
Yohimbine-induced stress would not necessarily be expected
to act as a reminder for the disrupted instrumental memory,
and so the lack of recovery in the present results might
be taken as support for retrieval impairment accounts of
instrumental memory reconsolidation deficits. However, the
different nature of stress-induced reinstatement might also point
towards reconsolidation being a storage deficit in the current
study. Stress has been argued, albeit typically when discussing
footshock stress, to interfere with behavioral inhibition, thereby
releasing instrumental responding from inhibition and leading
to relapse (Shaham et al., 2000). While this can explain
stress-induced reinstatement of instrumental responding that
is under inhibition, either following extinction or other forms
of retrieval inhibition, it would mean that stress would not
be expected to recover a genuine impairment in instrumental
memory storage.
Notably instrumental behaviors can be mediated via either
a ‘‘goal-directed’’ Action–Outcome (A–O) memory, or a
Stimulus–Response (S–R) ‘‘habit’’ (Dickinson, 1985). Previous
studies of reconsolidation have not demonstrated the disruption
of more than one association following a single reactivation
and drug treatment. Therefore, it is perhaps likely that only
one of the A–O and S–R memories was destabilized and
its reconsolidation impaired. Given our conclusion in sucrose
seeking that reactivation and MK-801 impaired the S–R
association (Exton-McGuinness et al., 2014), we might assume
that the A–O memory remained intact. This adds a further level
of complexity to the explanation for recovery of responding, as
it might not reflect recovery of the impaired S–R association, but
rather activation/enhancement of the preserved A–O memory,
especially as goal-directed responding appears to be actively
inhibited in the course of the development of S–R habits
(Coutureau and Killcross, 2003). Such an activation might be
achieved via a reminder process, for which exposure to the CS
and cocaine would again be expected to be effective. In contrast,
there is little evidence that stress can activate instrumental
responding; for example, single behavioral stress prior to a test
for pavlovian-instrumental transfer test did not increase baseline
instrumental responding (Pielock et al., 2013).
In summary, reconsolidation-disruption of instrumental
memory supporting cocaine-seeking can protect against stress-
induced relapse, as well as diminish spontaneous rates of
responding. However, little protection is afforded to cue-induced
and cocaine-induced relapse. This leaves open the possibility
that combined targeting of both instrumental and pavlovian
memories might provide greater resistance to relapse. Moreover,
a memory reactivation through non-contingent administration
of cocaine can protect against cocaine-induced relapse (Luo
et al., 2015). Interestingly, if it is the case that the targeting
of instrumental memory reconsolidation disrupts selectively
the S–R ‘‘habit’’ associations that are believed to be key
in driving addiction (Milton and Everitt, 2012), this may
leave behavior under adaptive goal-directed control. This
highlights the importance of translating the current findings
into experimental settings that evaluate addition-like behavior
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(e.g., Belin et al., 2008), as simple cocaine-seeking does not
necessarily afford insight into whether the measured behavior is
genuinely maladaptive.
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